Trial on S-ICD Implantation Without Defibrillation Testing Shows Non-Inferiority
The trial results on S-ICD implantation without defibrillation testing could significantly influence clinical practices and device adoption in cardiology. If proven non-inferior, this approach may lead to a shift towards less invasive procedures, affecting market dynamics and competitive positioning.
Phase III
Cardiology / Device Therapy
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
The trial results on S-ICD implantation without defibrillation testing could significantly influence clinical practices and device adoption in cardiology. If proven non-inferior, this approach may lead to a shift towards less invasive procedures, affecting market dynamics and competitive positioning.
Why it matters
The trial results on S-ICD implantation without defibrillation testing could significantly influence clinical practices and device adoption in cardiology. If proven non-inferior, this approach may lead to a shift towards less invasive procedures, affecting market dynamics and competitive positioning.
What changed
Trial Update
Analysis
A randomized trial is assessing whether S-ICD implantation without defibrillation testing is non-inferior to the standard method.
The trial results on S-ICD implantation without defibrillation testing could significantly influence clinical practices and device adoption in cardiology. If proven non-inferior, this approach may lead to a shift towards less invasive procedures, affecting market dynamics and competitive positioning.
Monitor trial results and subsequent guidelines from cardiology associations regarding S-ICD implantation practices.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.